The COVID-19 Pandemic
COVID-19 has become a battle between containment and the economy. Lockdown has brought many countries to its knees with high unemployment, plunging stock market and widespread disobedience against unaccustomed restriction of movements. Freedom of movement has led to spikes in affected cases, overcrowded hospitals and in the worst case, cram-full morgues.
A halfway solution, clearly needed, is mass testing and contact tracing to map the the spread of COVID-19 so that appropriate action can be taken quickly to contain new clusters and its spread. Immunoassay is the answer - the antibody test. The traditional nucleic acid PCR test, though accurate has weaknesses. Worldwide shortages of swaps slowed the rate of tests. Trained personnel performing the PCR tests are in short supply. There is only one answer - the COVID-19 Rapid test kit that gives results in 15 minutes. It can also be used at home without training needed
SARS-CoV-2 Rapid Antigen Test
Reliable, rapid chromatographic immunoassay for the qualitative detection of specific antigens of SARS-CoV-2
An aid in identifying individuals infected by SARS-CoV-215
The SARS-CoV-2 Rapid Antigen Test is a reliable, rapid chromatopgraphic immunoassay for the qualitative detection of specific antigens of SARS-CoV-2 present in the human nasopharynx.
This test is an aid in detecting antigen from the SARS-CoV-2 virus in individuals suspected of COVID-19. This product is strictly intended for professional use in laboratory and Point of Care environment.
Testing ready to go when you need to know
The reliable SARS-CoV-2 Rapid Antigen Test provides fast answers wherever you need them. It’s time to expand testing- because patients and their communities need to know.
Besides laboratory PCR testing, antigen assays can also be offered as rapid testing in near-patient settings. The SARS-CoV-2 Rapid Antigen Test is a rapid chromatographic immunoassay intended for the qualitative detection of specific antigens of SARS‑CoV‑2 present in nasopharyngeal or combined nasopharyngeal/oropharyngeal samples. This test is intended to detect antigen from the SARS‑CoV‑2 virus in individuals suspected of COVID‑19. This product is strictly intended for professional use in laboratory and Point of Care environments. Similar to laboratory instruments, it detects a SARS-CoV-2 antigen, the nucleoprotein. It can therefore be used to assess whether a person is infected with SARS-CoV-2 by providing a qualitative result showing coloured bands indicating the presence of SARS-CoV-2 antigens.
The SARS-CoV-2 Rapid Antigen Test enables fast decision making e.g. whether patients need to be put in quarantine, reducing the risk of further spreading. In addition to that it allows for screening of individuals after confirmed exposure to a SARS-CoV-2 infected person or individuals at risk of exposure such as healthcare workers.
The SARS-CoV-2 Rapid Antigen Test allows for decentralized testing at the point of care and helps to expand the range and quantity of direct virus testing into otherwise inaccessible locations. Rapid point of care testing can sometimes be the only viable option if lab testing is not sufficiently available. In addition to that, the SARS-CoV-2 Rapid Antigen Test is an instrument free test, allowing testing in rural/ low-infrastructure areas.
The benefits of the SARS-CoV-2 Rapid Antigen Test in short:
Getting a quick result within 15-30 minutes – no need for a follow-up appointment to discuss the result
Easy handling which does not require specific training
No instrument required
Allowing decentralized testing or access to testing in areas where laboratory testing is not available
